Cell Chemical Biology
Scope & Guideline
Bridging Disciplines to Transform Life Sciences.
Introduction
Aims and Scopes
- Chemical Biology Techniques:
The journal encompasses a wide range of chemical biology techniques, including chemical proteomics, bioorthogonal chemistry, and small molecule discovery, providing insights into cellular processes. - Targeted Protein Degradation:
A significant area of focus is on targeted protein degradation, including the development of PROTACs (proteolysis-targeting chimeras) and their applications in cancer therapy and other diseases. - Metabolism and Disease:
Research frequently explores the role of metabolism in disease, particularly cancer and infectious diseases, highlighting how metabolic pathways can be targeted for therapeutic interventions. - Immunology and Therapeutics:
The journal features studies on immunology, including immune modulation and therapeutic strategies involving antibodies and small molecules, emphasizing their potential in treating various conditions. - RNA Biology:
An important aspect of the journal includes the investigation of RNA biology, focusing on RNA modifications, non-coding RNAs, and their roles in cellular regulation and disease. - Chemical Genomics:
The intersection of chemical biology and genomics is a key theme, with research aimed at understanding gene function and regulation through chemical probes and small molecules.
Trending and Emerging
- Induced Proximity Techniques:
Research on induced proximity, particularly through the use of molecular glues and PROTACs, has gained significant attention, highlighting innovative strategies for targeted degradation and modulation of protein functions. - Chemical Immunology:
The field of chemical immunology is expanding, with increasing studies focused on immune-modulating compounds and their applications in immunotherapy, particularly in cancer treatment. - Metabolomics and Disease:
An emerging focus on metabolomics is evident, with studies investigating how metabolic changes influence disease states and the potential for targeting metabolic pathways in therapy. - RNA-targeting Therapeutics:
There is a growing interest in RNA-targeting strategies, including the development of small molecules that can modulate RNA function and stability, reflecting the increasing recognition of RNA's role in cellular processes. - Synthetic Biology and Gene Editing:
Synthetic biology approaches, including CRISPR and other gene editing technologies, are increasingly featured, emphasizing their potential for therapeutic applications and biological research. - Dynamic Cellular Imaging:
Advancements in live-cell imaging techniques are trending, allowing researchers to visualize cellular processes in real-time, thereby enhancing our understanding of complex biological systems.
Declining or Waning
- Traditional Drug Discovery Approaches:
There appears to be a waning interest in traditional high-throughput screening methods for drug discovery, as newer, more targeted approaches like PROTACs and chemical genomics gain prominence. - Basic Biochemical Pathway Studies:
Research that solely focuses on elucidating basic biochemical pathways without a clear application or therapeutic angle has decreased, as the journal emphasizes translational research and practical applications. - Static Imaging Techniques:
Static imaging techniques have become less favored compared to dynamic and live-cell imaging approaches, which provide real-time insights into cellular processes. - Single Target Approaches:
There is a noticeable reduction in studies focusing on single-target drug discovery, as the field increasingly embraces polypharmacology and multi-target strategies. - Enzyme Mechanism Studies:
While still relevant, in-depth studies purely focused on enzyme mechanisms without broader implications for therapeutic development or biological context have become less prevalent.
Similar Journals
PROTEIN AND PEPTIDE LETTERS
Advancing molecular insights through protein and peptide research.PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.
ACS Chemical Biology
Exploring the Molecular Foundations of LifeACS Chemical Biology is a premier journal published by the American Chemical Society, dedicated to advancing the understanding of the chemical underpinnings of biological systems. With an ISSN of 1554-8929 and a distinguished track record since its inception in 2006, this journal provides a vital platform for the dissemination of high-quality research in the realms of biochemistry and molecular medicine, achieving a prestigious Q1 ranking in these categories as of 2023. In an era where interdisciplinary approaches are crucial, ACS Chemical Biology fosters collaboration among chemists and biologists, reflecting a steadfast commitment to exploring the chemical processes that govern life. Although it does not operate under an open-access model, the journal maintains a rigorous peer-review process, ensuring the publication of influential studies that shape the future of chemical biology. With an increasing impact factor and a focus on innovative research, ACS Chemical Biology remains an authoritative resource for researchers, professionals, and students eager to engage with cutting-edge findings in this dynamic field.
LIFE SCIENCES
Fostering innovation in pharmacology and toxicology.LIFE SCIENCES, published by PERGAMON-ELSEVIER SCIENCE LTD, is an esteemed international journal that has been advancing the field since its inception in 1962. With an ISSN of 0024-3205 and an E-ISSN of 1879-0631, it serves as a critical forum for researchers, professionals, and students within the realms of biochemistry, genetics, molecular biology, medicine, and pharmacology. Currently ranked in the Q1 category across multiple disciplines, including a remarkable 2nd rank in General Pharmacology, Toxicology, and Pharmaceutics, the journal maintains a prestigious position in academic circles, evidenced by its high impact factor and significant percentile ranks. While LIFE SCIENCES is not an open-access journal, it remains dedicated to publishing high-quality, peer-reviewed research that pushes the boundaries of knowledge and fosters innovation. With converged research interests leading into 2024, LIFE SCIENCES continues to be a pivotal resource for the dissemination of influential findings, making it an indispensable tool for those engaged in the life sciences.
COMPUTATIONAL BIOLOGY AND CHEMISTRY
Bridging Disciplines: Where Computational Biology Meets ChemistryCOMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.
Nature Chemical Biology
Pioneering Insights in the Molecular Landscape of Life.Nature Chemical Biology is a prestigious academic journal published by NATURE PORTFOLIO, specializing in the interdisciplinary field of chemical biology. With an impressive impact factor and consistently ranked in the Q1 category for both Cell Biology and Molecular Biology, this journal serves as a vital platform for disseminating groundbreaking research and innovative methodologies. Covering a broad spectrum of topics that integrate the principles of chemistry and biology, it is particularly essential for researchers and professionals dedicated to understanding the molecular mechanisms of life. The journal is renowned for its rigorous peer-review process and high visibility, which contribute to its ranking of 14th in Molecular Biology and 17th in Cell Biology according to Scopus, placing it in the top percentiles of its fields. While open access options are limited, the journal remains a critical resource for students and academics striving to stay at the forefront of chemical biology research, from its inception in 2005 through to its convergence in 2024. By facilitating the exchange of knowledge and ideas, Nature Chemical Biology continues to shape the future of science and innovation.
Cell Reports
Advancing the Frontiers of Molecular DiscoveryCell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.
Chemical Biology Letters
Bridging Theory and Practice in BiochemistryChemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.
RSC Chemical Biology
Bridging Chemistry and Biology for Tomorrow's InnovationsRSC Chemical Biology is a prestigious journal published by the Royal Society of Chemistry, providing a significant platform for researchers in the fields of biochemistry, genetics, and molecular biology. Launched in 2020, the journal aims to disseminate high-quality research that bridges the gap between chemistry and biology, promoting interdisciplinary studies and innovations that are essential for advancements in life sciences. With an emerging impact factor and ranking in the top quartile (Q1) for multiple categories such as Biochemistry and Molecular Biology, RSC Chemical Biology holds a prominent position in the academic landscape, evidenced by its Scopus rankings placing it in the top 20% and 30% of its respective fields. Although it does not operate under an open-access model, the journal's commitment to accessibility is reflected in its rigorous peer-review process and its role in shaping future scientific discourse. Research published in this journal is vital for contributing to our understanding of complex biological processes and fostering innovations that can lead to real-world applications.
FEBS Journal
Fostering Knowledge and Innovation in Biochemical SciencesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Pioneering Insights in Biochemistry and MedicineMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.